Mu 935 News Today

DGAP-News: Immunic, Inc. / Key word(s): Patent Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor 02.02.2022 / 22:01 The issuer is solely responsible for the content of this annou...

DGAP-News: Immunic, Inc. / Key word(s): Study results Immunic, Inc. Publishes Positive Results from the Single and Multiple Ascending Dose Parts of its Phase 1 Clinical Trial of IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor 14.12.2021 / 12:30 The issuer is solely responsible for the ...